Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market Analysis and Forecast by Size, Share, Growth, Trends 2031

Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market Size and Forecast (2021-2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service (Economic Modelling or Evaluation, Real World Data Analysis and Information System, Market Access Solutions and Reimbursement, Clinical Outcome, Other Services), Service Provider (Contract Research Organizations and Consultancy), and End User (Biotechnology and Pharmaceutical Companies, Healthcare Payers, Government Organizations, and Healthcare Providers)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
  • Report Code : TIPRE00041427
  • Category : Life Sciences
  • No. of Pages : 127
  • Available Report Formats : pdf-format excel-format
Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Report Date: Oct 2025   |   Report Code: TIPRE00041427
Buy Now

The Middle East & Africa health economics and outcome research (HEOR) services market size is expected to reach US$ 114.15 million by 2031 from US$ 61.15 million in 2024. The market is estimated to record a CAGR of 9.3% from 2024 to 2031.

Executive Summary and Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market Analysis:

The MEA Health Economics and Outcomes Research (HEOR) Services Market is constantly growing, driven by rising healthcare needs and rising pharmaceutical activity. The region is made up of major countries such as the United Arab Emirates, Saudi Arabia, South Africa, and the remainder of MEA. Of these, Saudi Arabia is the largest and most vibrant market, driven by huge investments in health infrastructure as well as policy-led reforms under Vision 2030. A sharp increase in the incidence of chronic diseases like diabetes, cardiovascular disease, and cancer is enhancing demand for evidence-based healthcare solutions, driving the use of HEOR services.

Moreover, pharmaceutical and biotechnology firms are accelerating product launches throughout the region, looking for market access solutions and value-based results to address payer and regulatory requirements. Growing healthcare spending, with the support of public and private funding, continues to fuel the market climate. Therefore, the MEA HEOR services market is poised for long-term growth, offering big opportunities for stakeholders and service providers.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market: Strategic Insights

middle-east-and-africa-health-economics-and-outcome-research-heor-services-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market Segmentation Analysis:

Key segments that contributed to the derivation of the Middle East & Africa health economics and outcome research (HEOR) services market analysis are service, service provider, and end user.

  • Based on service, the Middle East & Africa health economics and outcome research (HEOR) services market is segmented into economic modelling or evaluation, real world data analysis and information system, market access solutions and reimbursement, clinical outcome, and others. The economic modelling or evaluation segment held the largest share of the market in 2024.
  • By service provider, the Middle East & Africa health economics and outcome research (HEOR) services market is bifurcated into contract research organizations and consultancy. The contract research organizations segment held a larger share of the market in 2024.
  • By end user, the Middle East & Africa health economics and outcome research (HEOR) services market is segmented into biotechnology and pharmaceutical companies, healthcare payers, government organizations, and healthcare providers. The biotechnology and pharmaceutical companies segment held the largest share of the market in 2024.

Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market Report Scope

Report Attribute Details
Market size in 2024 US$ 61.15 Million
Market Size by 2031 US$ 114.15 Million
CAGR (2024 - 2031) 9.3%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Service
  • Economic Modelling or Evaluation
  • Real World Data Analysis and Information System
  • Market Access Solutions and Reimbursement
  • Clinical Outcome
  • Others
By Service Provider
  • Contract Research Organizations
  • Consultancy
By End User
  • Biotechnology and Pharmaceutical Companies
  • Healthcare Payers
  • Government Organizations
  • Healthcare Providers
Regions and Countries Covered Middle East & Africa
  • Saudi Arabia
  • the UAE
  • South Africa
  • Rest of Middle East & Africa
Market leaders and key company profiles
  • PharmaLex GmbH
  • ICON Plc
  • IQVIA Holdings Inc
  • Syneos Health Inc
  • Optum Inc
  • Certara Inc.
  • ExlService Holdings, Inc.
  • Avalon Health Economics LLC
  • Axtria, Inc.
  • McKesson Corp

Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market Players Density: Understanding Its Impact on Business Dynamics

The Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

middle-east-and-africa-health-economics-and-outcome-research-heor-services-market-cagr

Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market Outlook

The broad healthcare industry has a constant demand for product development. The continuous product development activities provide quality products. Moreover, the rising incidence of acute and chronic diseases, growing demand for minimally invasive treatments, rising healthcare expenditure, and evolving technologies are propelling the demand for healthcare product development. The upgrading of healthcare systems and increasing technological development have offered technologies such as genomics, artificial intelligence, minimally invasive services, point-of-care services, and robotics treatments.

The main focus of the manufacturer is to offer cost-effective and efficient products in the market. Product development leads to better communication between the healthcare provider and patients. This results in an increased awareness and knowledge, leading to the company's and industrial growth. Health economics, and their outcomes are studied to drive better business. Designing a product and its lifecycle becomes difficult for market players in the developmental process. Various companies outsource HEOR services to understand the regulations, healthcare coverage, and access decisions and identify the intervention that would benefit the specific populations of patients. The HEOR's most essential service is helping players fill the gap between clinical trials and actual health outcomes.

The HEOR service providers help pharmaceutical, biotechnology, and medical device companies explain the value of their innovations to their respective stakeholders, such as physicians, payers, and patients. Thus, increasing product development is driving demand for HEOR services and fuels market growth.

Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market Country Insights

Based on country, the Middle East & Africa health economics and outcome research (HEOR) services market comprises Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held the largest share in 2024.

The HEOR service market is an emerging field in Saudi Arabia that offers vital information for healthcare coverage and access decisions. The rapid growth of pharmaceutical expenditure has led to an increased interest in the economic evaluation of healthcare interventions. The Ministry of Human Resources and Social Development, in line with Vision 2030, promotes job creation through workforce development programs in Saudi Arabia. The Vision 2030 initiative is essential to diversify the economy and modernize various sectors, including health. It has also been instrumental in integrating health economics and outcomes research (HEOR) into the national health strategy. This initiative emphasizes value-based care, focusing on patient outcomes and cost-effectiveness, which creates an environment for HEOR methodologies to flourish.

The shift from traditional fee-for-service models to value-based reimbursement systems is driving the adoption of HEOR. Healthcare providers are striving to optimize resource allocation and improve patient access to innovative treatments. As a result, they are increasingly relying on HEOR studies to inform their decisions. This development is also supported by a growing job market for qualified HEOR professionals, as local and multinational organizations seek skills in economic modeling and real-world data analysis.

Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market Company Profiles

Some of the key players operating in the market include PharmaLex GmbH; ICON Plc; IQVIA Holdings Inc; Syneos Health Inc; Optum Inc; Certara Inc.; ExlService Holdings, Inc.; Avalon Health Economics LLC; Axtria, Inc.; and McKesson Corp, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Health Economics and Outcome Research (HEOR) Services Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations.
  • Industry trade journals and other relevant publications.
  • Government documents, statistical databases, and market reports.
  • News articles, press releases, and webcasts specific to companies operating in the market.

Note:

All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research.
  • Enhance the expertise and market understanding of the analysis team.
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA
Page Updated: Dec 2025